Welcome, Guest. Please login or register.
December 13, 2024, 05:27:29 pm

Login with username, password and session length


Members
  • Total Members: 6315
  • Latest: DRG
Stats
  • Total Posts: 55135
  • Total Topics: 4853
  • Online Today: 258
  • Online Ever: 3061
  • (September 25, 2024, 11:40:40 pm)
Users Online
Users: 0
Guests: 261
Total: 261

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Hep C Testing and Treatment Rates Are High Among Australians Who Inject Drugs  (Read 5949 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
In Australia, where access to direct-acting antiviral (DAA) treatment has been unrestricted since March 2016, people who inject drugs (PWID) have high rates of hepatitis C virus (HCV) testing and treatment.

Presenting their findings at the 53rd International Liver Congress in Vienna, Australian researchers from the ETHOS Engage study enrolled 507 PWID between May and November 2018. The participants were all attending drug treatment clinics or syringe services programs. Seventy percent of the group had injected drugs during the previous month, and 70 percent were currently receiving medication-assisted treatment (MAT) for opioid use disorder (OUD).

Read more...
https://www.hepmag.com/article/hep-c-testing-treatment-rates-high-among-australians-inject-drugs

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.